why choose us

Clinical Trials Search

Showing 16,120 of 132,656 result(s)
Janus Kinase Inhibition in Sarcoidosis

Status: COMPLETED

Condition: Sarcoidosis

Interventions: Abrocitinib (Cibinqo) is FDA approved at 200 mg dose once daily for the treatment of atopic dermatitis.
It is not currently FDA approved for the

Date: 2023-01-13

Non-pharmacological Methods for the Control of Anxiety and Pain During Outpatient Hysteroscopy

Status: COMPLETED

Condition: Pain, Postoperative

Interventions: In-office hysteroscopic procedures were conducted using a 5mm continuous flow Office Hysteroscope using a vaginoscopic, no-touch, approach

Date: 2023-01-13

Study of Virtual Reality-based Medical Device for Patients with Depressive Disorder

Status: COMPLETED

Condition: Depressive Disorder

Interventions: This software medical device consists of multifaceted interventions (breathing training, cognitive rehabilitation training, binaural beat training, co

Date: 2023-01-12

Using Non-Weightbearing Stationary Elliptical Machines for Patients with Chronic Low Back Pain

Status: COMPLETED

Condition: Chronic Low-back Pain

Interventions: Patients will receive routine physiotherapy protocols as well as Non-weightbearing stationary elliptical

Date: 2023-01-12

Transcutaneous Vagus Nerve Stimulation (tcVNS) in JIA

Status: COMPLETED

Condition: Juvenile Idiopathic Arthritis (JIA)

Interventions: tcVNS is administered with a study device that gives off mild electrical impulses through the skin to stimulate the vagus nerve (a nerve that travels

Date: 2023-01-12

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia

Status: COMPLETED

Condition: Schizophrenia

Interventions: In Period 1, 2 monthly injections.
In Period 2, up to 12 monthly injections

Date: 2023-01-12

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Status: COMPLETED

Condition: Epstein-Barr Virus Infection

Interventions: Matrix-M1 is composed of 2 types of 40 nm-sized particles each with a different saponin fraction (fraction A and fraction B) combined with cholesterol

Date: 2023-01-12

Evaluation of Neuronal Damage in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy With Biomarkers

Status: Completed

Condition: Brain Damage

Interventions: MMSE and MoCA will be applied preoperative,postoperative first day and fourth day S100B,GFAP and NSE will be measured in blood tests preoperative,post

Date: 2023-01-12

Accelerated Corneal Collagen Crosslinking Protocols

Status: Completed

Condition: Keratoconus

Interventions: Epithelium-off accelerated corneal crosslinking is a procedure in which the cornea is soaked with riboflavin followed by exposure to ultraviolet irrad

Date: 2023-01-12

Pericapsular Nerve Block Versus Interscalene Nerve Block for Acute Pain Management in Shoulder Arthroscopy

Status: Completed

Condition: Pericapsular Nerve Block

Interventions: patients received Ultrasound guided pericapsular nerve group block using 20 ml of bupivacaine 0.5%

Date: 2023-01-12